Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 2/20 | 1.00 |
| ▸ | CCR5 | P51681 | 2/20 | 1.00 |
| ▸ | CCR8 | P51685 | 2/20 | 1.00 |
| ▸ | METAP2 | P50579 | 1/20 | 0.63 |
| ▸ | UHRF1 | Q96T88 | 1/20 | 0.62 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | NOS2 | P35228 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | NOS3 | P29474 | 1/20 | 0.56 |
| ▸ | NOS1 | P29475 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | PLAU | P00749 | 1/20 | 0.45 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.43 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.43 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.43 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.43 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.43 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.43 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29397106 | 1.00 | CCR1 (1.00) | CCR1CCR5CCR8METAP2UHRF1 | |
| SCHEMBL2258309 | 0.97 | CCR1 (0.94) | CCR1CCR5CCR8METAP2UHRF1 | |
| Hydrochloric Acid SCHEMBL9639295 | 0.97 | CCR1 (0.94) | CCR1CCR5CCR8METAP2UHRF1 | |
| SCHEMBL31482991 | 0.97 | CCR1 (0.94) | CCR1CCR5CCR8METAP2UHRF1 | |
| SCHEMBL6820852 | 0.97 | CCR1 (0.94) | CCR1CCR5CCR8METAP2UHRF1 | |
| SCHEMBL6820765 | 0.97 | CCR1 (0.94) | CCR1CCR5CCR8METAP2UHRF1 | |
| Hydrochloric Acid SCHEMBL5549447 | 0.97 | CCR1 (0.94) | CCR1CCR5CCR8METAP2UHRF1 | |
| SCHEMBL31482988 | 0.97 | CCR1 (0.94) | CCR1CCR5CCR8METAP2UHRF1 | |
| SCHEMBL15664136 | 0.97 | CCR1 (0.94) | CCR1CCR5CCR8METAP2UHRF1 | |
| SCHEMBL32670845 | 0.97 | CCR1 (0.94) | CCR1CCR5CCR8METAP2UHRF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3212 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260137312-A1 | MEASUREMENT OF GLUCOSE NEAR AN INSULIN DELIVERY CATHETER BY MINIMIZING THE ADVERSE EFFECTS OF INSULIN PRESERVATIVES: ALTERNATIVE LIGANDS AND REDOX MEDIATOR METALS | PACIFIC DIABETES TECH INC (US) | 2026-05-21 | — | — | US | claimed |
| US-12630725-B2 | Color enhancement utilizing up converters and/or down converters | IMMUNOLIGHT, LLC (US) | 2026-05-19 | — | — | US | claimed |
| US-12616848-B2 | Energy augmentation structures, energy emitters or energy collectors containing the same, and their use in solar cells and other energy conversion devices | IMMUNOLIGHT, LLC (US) | 2026-05-05 | — | — | US | claimed |
| US-12611504-B2 | Methods and systems for insulin delivery and glucose measurement | Pacific Diabetes Technologies, Inc. (US) | 2026-04-28 | — | — | US | claimed |
| EP-4727953-A2 | ACCELERATED MARKING OF 5-FORMYL CYTOSINE AND USE IN NUCLEIC ACID METHYLATION SEQUENCING | F. Hoffmann-La Roche AG (CH) | 2026-04-22 | — | — | EP | claimed |
| US-12495995-B2 | Measurement of glucose near an insulin delivery catheter by minimizing the adverse effects of insulin preservatives: alternative ligands and redox mediator metals | PACIFIC DIABETES TECHNOLOGIES, INC (US) | 2025-12-16 | — | — | US | claimed |
| US-20250375458-A1 | COMPOSITIONS AND METHODS TO COMBAT MULTIDRUG-RESISTANT AND PERSISTENT T-CELL-MEDIATED, ONCOLOGICAL AND INFECTIOUS DISEASES | THERALASE TECH INC (CA) | 2025-12-11 | — | — | US | claimed |
| US-20250375511-A1 | METHOD FOR TREATING CONDITIONS ASSOCIATED WITH HYPERPROLIFERATING CELLS COMPRISING COMBINED ADMINISTRATION OF INFECTIOUS AGENTS AND METAL CATIONS | THERALASE TECH INC (CA) | 2025-12-11 | — | — | US | claimed |
| US-20250362307-A1 | PHOTOACTIVE ANTIBODY CONJUGATE | LIAO JUNG CHI (TW) | 2025-11-27 | — | — | US | claimed |
| US-12478734-B2 | Methods and systems for insulin delivery and glucose measurement | PACIFIC DIABETES TECHNOLOGIES INC. (US) | 2025-11-25 | — | — | US | claimed |
| US-4954414-A | Photosensitive composition containing a transition metal coordination complex cation and a borate anion and photosensitive materials employing the same | THE MEAD CORPORATION (US) | 1990-09-04 | — | — | US | claimed |
| EP-0096288-B1 | PROCESS FOR THE ELECTROCHEMICAL HYDROGENATION OF NICOTIN-AMIDE-ADENINE DINUCLEOTIDE | BASF Aktiengesellschaft (DE) | 1985-08-21 | — | — | EP | claimed |
| EP-0075174-B1 | PROCESS FOR THE PREPARATION OF 4-NITRODIPHENYL AMINES | BAYER AG (DE) | 1985-08-07 | — | — | EP | claimed |
| US-4526661-A | Employing as electron carrier a metal complex having reduction potential which is not more negative than-1.3 volts at 10-70 degrees C. | BASF AKTIENGESELLSCHAFT (US) | 1985-07-02 | — | — | US | claimed |
| EP-0096288-A1 | Process for the electrochemical hydrogenation of nicotin-amide-adenine dinucleotide | BASF Aktiengesellschaft (DE) | 1983-12-21 | — | — | EP | claimed |
| US-4404352-A | ORGANOTIN COMPOUNDS AS CATALYST AND AMINES TO GIVE CURED COATINGS WITH PARTIALLY BLOCKED ISOCYANATES | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1983-09-13 | — | — | US | claimed |
| US-4404400-A | REACTION OF AN ANILINE WITH A HALOGENONITROBENZENE | BAYER AKTIENGESELLSCHAFT (DE) | 1983-09-13 | — | — | US | claimed |
| EP-0075174-A1 | Process for the preparation of 4-nitrodiphenyl amines | BAYER AG (DE) | 1983-03-30 | — | — | EP | claimed |
| EP-0073835-A1 | PROCESS FOR PRODUCING POLYURETHANE POLYMER | Yoshitomi Pharmaceutical Industries, Ltd. (JP) | 1983-03-16 | — | — | EP | claimed |
| US-4086229-A | Dinitrosyldihalo complexes of molybdenum or tungsten | PHILLIPS PETROLEUM COMPANY (US) | 1978-04-25 | — | — | US | claimed |